| Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using theFDA-Adverse Event Reporting System Database Stratified by Age. | Int J Med Sci | 2015 Mar 28 | 25897292 |
| Profile of betrixaban and its potential in the prevention and treatment of venousthromboembolism. | Vasc Health Risk Manag | 2015 Jun 26 | 26170684 |
| High intra- and inter-individual variability of plasma vitamin K concentrationsin patients with atrial fibrillation under warfarin therapy. | Eur J Clin Nutr | 2015 Jun | 25828628 |
| Direct oral anticoagulants: efficacy and safety in patient subgroups. | Swiss Med Wkly | 2015 Feb 6 | 25658756 |
| Recent advances in the development of specific antidotes for target-specific oralanticoagulants. | Pharmacotherapy | 2015 Feb | 25644580 |
| Incidence of drug interaction when using proton pump inhibitor and warfarinaccording to cytochrome P450 2C19 (CYP2C19) genotype in Japanese. | Thorac Cardiovasc Surg | 2015 Feb | 25068772 |
| An electrochemical sensor for warfarin determination based on covalentimmobilization of quantum dots onto carboxylated multiwalled carbon nanotubes andchitosan composite film modified electrode. | Mater Sci Eng C Mater Biol Appl | 2015 Dec 1 | 26354242 |
| Evaluating Patients' Understanding of Printed Warfarin Medication Information. | J Pharm Pract | 2015 Dec | 25147159 |
| Evaluation of In-Use Stability of Anticoagulant Drug Products: Warfarin Sodium. | J Pharm Sci | 2015 Dec | 26501849 |
| A new kid on the block: Outcomes with Kcentra 1 year after approval. | J Trauma Acute Care Surg | 2015 Dec | 26488322 |